Novartis | 売上原価



Cost Of Sales 変化する 日付
AbbVie USD 4B 394M 2025-03
Amgen USD 2.6B 507M 2025-03
AstraZeneca USD 2.47B 232M 2025-06
Bausch Health Companies USD 701M 26M 2025-03
Biogen USD 605M 24.3M 2025-06
Bristol-Myers Squibb USD 3.37B 339M 2025-06
Canopy Growth CAD 50.66M 9.51M 2024-12
Corcept Therapeutics USD 2.4M 553K 2025-03
Drreddys Laboratories INR 34.53B 2.14B 2024-12
Eli Lilly USD 2.22B 179.6M 2025-03
Gilead Sciences USD 1.54B 41M 2025-03
GlaxoSmithKline GBP 2.16B 241M 2025-06
Glaxosmithkline GBP 2.52B 199M 2024-12
J&J USD 7.6B 304M 2025-06
Merck USD 2.82B 53M 2025-06
Novartis USD 3.32B 95M 2025-06
Novartis USD 3.31B 73M 2024-12
Pacira USD 34.31M 5.58M 2025-03
Perrigo USD 651.6M 100.8M 2025-03
Pfizer USD 2.59B 3.06B 2025-03
Prestige Brands USD 126.51M 2.76M 2025-03
Roche Holding CHF 4.13B 393.5M 2024-12
Sanofi EUR 2.89B 618M 2025-03
Sanofi EUR 2.27B 1.81B 2024-12
Supernus Pharmaceuticals USD 17.2M 385K 2024-12
Zoetis USD 622M 85M 2025-03


Novartis 売上原価 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Aug 2025.